It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
World shares India’s pain with growing COVID-19 crisis

Editorials May 8, 2021

World shares India’s pain with growing COVID-19 crisis

The WHO estimates that 25% of global deaths last week occurred in India, a death toll that exceeded 3,700 lives per day.

Japan pharma industry opposes U.S. backing for vaccine patent waiver

National May 8, 2021

Japan pharma industry opposes U.S. backing for vaccine patent waiver

The Japan Pharmaceutical Manufacturers Association said it is concerned that noneffective products may circulate, and the risk of side effects could increase as well.

The world turns to China for vaccines after India and U.S. stumble

Asia Pacific May 7, 2021

The world turns to China for vaccines after India and U.S. stumble

by Iain Marlow, Sudhi Ranjan Sen and James Paton

Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.

Biden's vaccine-patent gambit turns up the heat on drugmakers

World May 7, 2021

Biden's vaccine-patent gambit turns up the heat on drugmakers

by Josh Wingrove

By supporting the World Trade Organization process, the U.S. president can satisfy progressives while engaging in talks on a waiver that may never reach consensus.

In a reversal, U.S. backs giving poorer countries access to COVID-19 vaccine patents and tech

World May 6, 2021

In a reversal, U.S. backs giving poorer countries access to COVID-19 vaccine patents and tech

"This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures," Biden's top trade negotiator said in a statement

White House backs Pfizer’s move to begin vaccine exports

World May 4, 2021

White House backs Pfizer’s move to begin vaccine exports

by Josh Wingrove

Early U.S. production wasn’t subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.

Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds

World / Science & Health May 1, 2021

Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds

A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.

Japan to approve Moderna vaccine as soon as May 21, report says

National May 1, 2021

Japan to approve Moderna vaccine as soon as May 21, report says

The Moderna vaccine would be the second to get approved in Japan and will be used in the nation’s large inoculation centers that will open in Tokyo and Osaka from May 24, the report said.

First batch of Moderna COVID-19 vaccine arrives in Japan

National Apr 30, 2021

First batch of Moderna COVID-19 vaccine arrives in Japan

It will become the second type of shot available in the country after the one developed by Pfizer Inc. if a health ministry panel greenlights it as early as May 20.

With large vaccine studies harder to carry out, regulators look for alternatives

National / Science & Health Apr 30, 2021

With large vaccine studies harder to carry out, regulators look for alternatives

The start of inoculation campaigns has made it difficult for some nations to recruit a sufficient number of test subjects who have no immunity against the coronavirus.

COVID-19 shots come in bulk, but the world needs single servings

World / Science & Health Apr 30, 2021

COVID-19 shots come in bulk, but the world needs single servings

by Emma Court

Vials full of doses often must be kept in extreme cold, and once opened have to be used quickly, making delivery to smaller, far-flung populations difficult.

Dark horse of vaccine race may be this French biotech

World / Science & Health Apr 29, 2021

Dark horse of vaccine race may be this French biotech

by Suzi Ring

With the other COVID-19 vaccines in Europe focused on the virus’s spike protein, this shot could protect against variants that might compromise others, making it the perfect booster.

« 1 … 15 16 17 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times